Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention

被引:284
|
作者
Hayes, JD [1 ]
McMahon, M [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
关键词
chemoprevention; detoxication; antioxidant responsive element; Nrf1; Nrf2; cytochrome P450; glutathione S-transferase; mitogen activated protein kinase; carcinogenesis; protein kinase C;
D O I
10.1016/S0304-3835(01)00695-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article provides an overview of the mechanisms by which cancer chemopreventive blocking agents increase the expression of detoxication and antioxidant genes. These agents all appear capable of transcriptionally activating a gene battery that includes NAD(P)H:quinone oxidoreductase, aldo-keto reductases, glutathione S-transferases, gamma -glutamylcysteine synthetase, glutathione synthetase and heme oxygenase. Gene induction occurs through the antioxidant responsive element (ARE), a process that is dependent on the Nuclear Factor-Erythroid 2p45-related factors, Nrf1 and Nrf2. Under basal conditions, these basic region leucine zipper (bZIP) transcription factors are located in the cytoplasm of the cell bound to Keap1, and upon challenge with inducing agents, they are released from Keap1 and translocate, to the nucleus. Within the nucleus, Nrf1 and Nrf2 are recruited to the ARE as heterodimers with either small Maf proteins, FosB, c-Jun, JunD, activating transcription factor 2 (ATF2) or ATF4. The role of protein kinases in transducing chemical stress signals to the bZIP factors that affect gene induction through the ARE is discussed. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 50 条
  • [1] The molecular basis of retinoids' use in breast cancer chemoprevention
    Karamouzis, Michalis V.
    Konstantinopoulos, Panagiotis A.
    Papavassiliou, Athanasios G.
    [J]. CELLULAR ONCOLOGY, 2007, 29 (03): : 183 - 184
  • [2] The genetic and molecular basis for chemoprevention
    Hong, WK
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 15 - 15
  • [3] International Meeting on Cancer Chemoprevention: Molecular Basis, Mechanisms and Trials
    Bartsch, H
    Frank, N
    Gerhauser, C
    Owen, RW
    Berger, MR
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 1997, 6 (01) : 80 - 92
  • [4] Molecular Basis for Cancer Chemoprevention by Green Tea Polyphenol EGCG
    Tachibana, Hirofumi
    [J]. FOOD FACTORS FOR HEALTH PROMOTION, 2009, 61 : 156 - 169
  • [5] Cancer chemoprevention by antioxidant luteolin
    Naiki-Ito, Aya
    Kato, Hiroyuki
    Naiki, Taku
    Takahashi, Satoru
    [J]. CANCER SCIENCE, 2021, 112 : 1004 - 1004
  • [6] Cellular response to cancer chemopreventive agents: contribution of the antioxidant responsive element to the adaptive response to oxidative and chemical stress
    Hayes, JD
    Ellis, EM
    Neal, GE
    Harrison, DJ
    Manson, MM
    [J]. CELLULAR RESPONSES TO STRESS, 1999, (64): : 141 - 168
  • [7] A Rational Basis for Chemoprevention of Prostate Cancer
    Huang, Caroline J.
    Baum, Matthew L.
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2011, 11 (12): : 27 - 29
  • [8] Cancer chemoprevention: Selenium as a prooxidant not an antioxidant
    Drake, E. N.
    [J]. MEDICAL HYPOTHESES, 2006, 67 (02) : 318 - 322
  • [9] Antioxidant Marine Products in Cancer Chemoprevention
    Park, Eun-Jung
    Pezzuto, John M.
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2013, 19 (02) : 115 - 138
  • [10] The contribution of epidemiology and molecular biology for identifying population groups eligible for cancer chemoprevention
    Kelloff, GJ
    Boone, CW
    Malone, WF
    Nayfield, SG
    Hawk, ET
    Crowell, JA
    Lubet, RA
    Steele, VE
    Sigman, CC
    [J]. SCIENTIFIC BASES OF CANCER CHEMOPREVENTION, 1996, 1120 : 75 - 92